Community Hypertension Patients’ Preferences for Family Doctor Service Packages in China: A Discrete Choice Experiment
Therapeutic certainty significantly outweighs economic considerations for community hypertension patients, with the pronounced preference for original-brand medications serving as a critical proxy for clinical safety. Policy should encompass state-led support for original-drug development while simultaneously enhancing institutional trust in generic alternatives through transparent quality evidence. Transitioning toward stratified, patient-centered management is essential to address preference heterogeneity and improve the substantive effectiveness of the family doctor system in China.
Authors
- Yuan He (ORCID: https://orcid.org/0000-0002-8761-9070)
- Zixin Gu (ORCID: https://orcid.org/0009-0004-1875-7770)
- Yihong Cheng
- Yubo He
- Peilin Su
- Zixuan Zhang
- Guofeng Yue
Institutions
- Nanjing Medical University (CN)
Publication Details
- Journal
- Risk Management and Healthcare Policy
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/rmhp.s574616
- Primary Topic
- Economic and Environmental Valuation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society of Physiological Anthropology
- Jiangsu Pharmaceutical Association
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Qinglan Project of Jiangsu Province of China